Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON38958
NL-OMON38958
Completed
Not Applicable

ong-term clinical follow-up study of patients and families with choroideremia for future clinical trials - Follow-up choroideremia

Academisch Medisch Centrum0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCHMChoroideremiatapetochoroideal dystrophy (TCD)1001592010010463

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
CHM
Sponsor
Academisch Medisch Centrum
Enrollment
50
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients who are diagnosed with choroideremia based on ophthalmologic examination by an ophthalmologist and (often) confirmed by DNA\-analysis. Patients were included if they are male gender, aged \*18 years of age and able to provide written informed consent.

Exclusion Criteria

  • •There are no exclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2016-000297-38-BEInstitut de Recherches Internationales Servier (I.R.I.S)200
Active, not recruiting
Phase 1
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2016-000297-38-FRInstitut de Recherches Internationales Servier (I.R.I.S)200
Active, not recruiting
Phase 1
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0 Level: LLT Classification code 10060390 Term: Leukaemia lymphoblastic acute System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2016-000297-38-ESInstitut de Recherches Internationales Servier (I.R.I.S)200
Recruiting
Not Applicable
ong-term follow-up study of patients who have previouslybeen exposed to UCART19
JPRN-jRCT2013190001clinical operation department International center for therapeutic research200
Active, not recruiting
Phase 1
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19 or ALLO-501Advanced lymphoid malignanciesMedDRA version: 21.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10008958Term: Chronic lymphocytic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2016-000297-38-GBInstitut de Recherches Internationales Servier (I.R.I.S)200